New papers, trial results, methods, replication and the evidence beneath the headline.
A new study identifies a molecular pathway connecting exercise-related blood signals with cartilage health. Human blood samples informed the research, but therapeutic benefits remain untested in patients.
The experimental eloralintide–tirzepatide combination produced encouraging sponsor-reported results in adults with type 2 diabetes. Treatment discontinuations and the analysis assumptions remain central to interpreting the findings.
Newly released TRIUMPH-2 findings strengthen evidence for the investigational drug in adults with excess weight and type 2 diabetes. Different statistical analyses yield different weight-loss estimates, while long-term health benefits remain unresolved.
New research complicates the assumption that cellular recycling uniformly declines with age. Its preliminary findings also highlight why measuring biological activity does not automatically establish a health benefit.
The announcement marks the platform’s entry into human testing. The candidate and trial details remain undisclosed, and no human results were released.
A September 28 research update highlights a small randomized trial of noninvasive stimulation for uncontrolled hypertension. A possible benefit in a small subgroup remains preliminary.
Researchers developed EHR-AGE using diagnosis histories from Hungary’s population records. The findings support further study of an accessible aging measure, while its value for clinical decisions remains unestablished.
Laboratory findings suggest a possible role alongside radiation, but tumor selectivity and patient benefit remain unestablished.
A randomized study in older adults separates a biochemical response from evidence of functional benefit. The findings leave broader healthy-aging claims unresolved.
A small observational study linked faster epigenetic aging in participants in their forties to later everyday memory complaints. The study found no significant overall association across the sample and does not establish a dementia screening test.
A multi-cohort study connects menopause-related protein patterns with poorer cognitive outcomes in older women. The findings identify research candidates but do not establish a clinical screening test or a preventive treatment.
A small observational study links the osteoporosis peptide drug to increased bone density near the knee after replacement surgery. Whether that translates into fewer fractures or more durable implants remains unresolved.
Newly published research links the metabolic supplement to smaller tumors in female mice and larger tumors in males in one experimental model. The findings underscore uncertainties about translating animal longevity research into human benefits.
Researchers linked Neisseria flavescens to aging-related profiles in people and tested it in worms and mice. The findings nominate a research candidate but do not establish a human longevity intervention.
Researchers report changing blood-protein patterns in 197 patients receiving lecanemab. The observational findings suggest possible monitoring tools, but do not establish a validated test of individual treatment benefit.
Researchers mapped gene activity across 284 human brain donors, identifying distinct patterns across development, adulthood and aging. The findings provide a research reference but do not establish a treatment or a test of individual dementia risk.
Newly published research combines experimental retinal-barrier findings with a 24-patient safety study. The results support larger trials but do not establish that the oral drug prevents vision loss.
An observational analysis of 2,418 adults connects long-term employment patterns with later cognitive performance. The findings do not establish that postponing retirement prevents dementia.
A newly published study links catestatin to reduced tau pathology and amyloid burden in experimental models. The findings support further peptide research but establish no treatment benefit in people.
The full randomized trial report strengthens the evidence behind a negative result first announced in 2025. It illustrates the gap between modifying a cellular stress pathway and preserving patients’ function.
ResearchVitalspan Wire conceptual illustrationA transparent ladder from cell studies to replicated human outcomes—and the language we use at each rung.
ResearchVitalspan Wire conceptual illustrationA reader's checklist for endpoints, controls, conflicts, sample size and the gap between a biomarker and a health outcome.